发明名称 COMPOUNDS USEFUL IN CFTR ASSAYS AND METHODS THEREWITH
摘要 The present invention relates to compounds useful in CFTR assays. The present invention also relates to compounds useful in monitoring CFTR activity in therapies for CFTR-mediated diseases. The present invention also provides an assay for use in measuring CFTR correction.
申请公布号 US2015293078(A1) 申请公布日期 2015.10.15
申请号 US201514689860 申请日期 2015.04.17
申请人 Vertex Pharmaceuticals Incorporated 发明人 Singh Ashvani K.;Van Goor Fredrick F.;Worley, III Jennings Franklin;Knapp Thomas
分类号 G01N33/50 主分类号 G01N33/50
代理机构 代理人
主权项 1. A method for evaluating the ability of a compound to increase the number of CFTR on a cell, comprising the steps of: (i) contacting said cell with said compound under a first suitable conditions; (ii) contacting said cell with a compound of formula I under a second suitable conditions; and (iii) comparing the activity of CFTR on said cell in the presence and absence of said compound;wherein said compound of formula I is:wherein: Ar1 is a 5-6 membered aromatic monocyclic ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, wherein said ring is optionally fused to a 5-12 membered monocyclic or bicyclic, aromatic, partially unsaturated, or saturated ring, wherein each ring contains 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, wherein Ar1 has m substituents, each independently selected from —WRW; W is a bond or is an optionally substituted C1-C6 alkylidene chain wherein up to two methylene units of W are optionally and independently replaced by —CO—, —CS—, —COCO—, —CONR′—, —CONR′NR′—, —CO2—, —OCO—, —NR′CO2—, —O—, —NR′CONR′—, —OCONR′—, —NR′NR′, —NR′NR′CO—, —NR′CO—, —S—, —SO, —SO2—, —NR′—, —SO2NR′—, NR'SO2—, or —NR′SO2NR′—; RW is independently R′, halo, NO2, CN, CF3, or OCF3; m is 0-5; each of R1, R2, R3, R4, and R5 is independently —X—RX; X is a bond or is an optionally substituted C1-C6 alkylidene chain wherein up to two methylene units of X are optionally and independently replaced by —CO—, —CS—, —COCO—, —CONR′—, —CONR′NR′—, —CO2—, —OCO—, —NR′CO2—, —O—, —NR′CONR′—, —OCONR′—, —NR′NR′, —NR′NR′CO—, —NR′CO—, —S—, —SO, —SO2—, —NR′—, —SO2NR′—, NR'SO2—, or —NR′SO2NR′—; RX is independently R′, halo, NO2, CN, CF3, or OCF3; R6 is hydrogen, CF3, —OR′, —SR′, or an optionally substituted C1-6 aliphatic group; R7 is hydrogen or a C1-6 aliphatic group optionally substituted with —X—RX; R′ is independently selected from hydrogen or an optionally substituted group selected from a C1-C8 aliphatic group, a 3-8-membered saturated, partially unsaturated, or fully unsaturated monocyclic ring having 0-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-12 membered saturated, partially unsaturated, or fully unsaturated bicyclic ring system having 0-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or two occurrences of R′ are taken together with the atom(s) to which they are bound to form an optionally substituted 3-12 membered saturated, partially unsaturated, or fully unsaturated monocyclic or bicyclic ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur.
地址 Boston MA US